Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Emergent Ventures through the Thistledown Foundation
Grant: #2161
Emergent Ventures through the Thistledown Foundation
Grant: #2189
National Institute of Health
Grant: P01AI120943, R01AI123926 and R01AI161374
Canadian Institutes of Health Research
Grant: OV3-170346
Canadian Institutes of Health Research
Grant: #OV3-170649
HORIZON EUROPE
Grant: 952373
FWCI
2.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals